Piper Sandler Maintains Buy Rating and $130 Price Target on Incyte

Piper Sandler analyst Allison Bratzel has maintained a Buy rating on Incyte Corporation (ticker: INCY) and reaffirmed a price target of $130 for the company's shares. This update was issued on October 21, 2026.